# Soy Supplementation and Gestational Diabetes

> **NCT02806739** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Massachusetts, Boston** · enrollment: 40 (actual)

## Conditions studied

- Gestational Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Soy Group (Soy Protein + Isoflavones)
- **DIETARY_SUPPLEMENT:** Control Group (Minimize Soy Intake)

## Key facts

- **NCT ID:** NCT02806739
- **Lead sponsor:** University of Massachusetts, Boston
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806739, "Soy Supplementation and Gestational Diabetes". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT02806739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*